Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stanislav Poyarkov"'
Publikováno v:
Current Molecular Medicine. 23:239-249
Due to a large number of identified hub-genes, encoding key molecular regulators, which involve in signal transduction and metabolic pathways in cancers, it is relevant to systemize and update these findings.Colorectal cancer (CRC) is the third leadi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530a892a75ff919bfa71ee598a3119c0
https://doi.org/10.2174/1566524022666220427102048
https://doi.org/10.2174/1566524022666220427102048
Autor:
Andrey Ivashchenko, Valeria Azarova, Alina Egorova, Ruben Karapetian, Dmitry Kravchenko, Natalia Krivonos, Vladimir Loginov, Stanislav Poyarkov, Elena Merkulova, Olga Rosinkova, Nikolay Savchuk, Mikhail Topr, Elena Simakina, Elena Yakubova, Alexandre Ivachtchenko
Objectives. COVID-19 is a contagious multisystem inflammatory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have studied the efficacy of Aprotinin (nonspecific serine proteases inhibitor) and Avifavir or Hydrox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1876dc8f4692fee52b4373f46ce3dc55
https://doi.org/10.21055/preprints-3111905
https://doi.org/10.21055/preprints-3111905
Autor:
Stanislav Poyarkov, Maria S. Pokrovskaya, Aalexey Novoselov, Tamara Mania, Marina Aksenova, Zlata Fedec, Anna Makovezkaya, Angelika V. Zagainova, Valentin V. Makarov, Andrey Kirilov, Lyudmila Khripach, Oxana Drapkina, Sergey Yudin, Anastasia Kaburova, Boris Zaitchik
Background Chronic heart failure (CHF) affects approximately 26 million people worldwide. Nearly half of CHF patients develop heart failure with preserved ejection fraction (HFpEF), which is associated with myocardial hypertrophy and fibrosis. Althou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2da95e0809d6adc0471519153c63f30
https://doi.org/10.21203/rs.3.rs-94727/v1
https://doi.org/10.21203/rs.3.rs-94727/v1
Autor:
Andrey Ivashchenko, Andrey Svistunov, Tatiana Khorobryh, Vladimir Loginov, Ruben Karapetian, Natalia Mishchenko, Stanislav Poyarkov, Michael Topr, Maksim Volgin, Elena Yakubova, Alexandre Ivachtchenko
Aprotinin showed high efficacy and safety in a prospective study of combination therapy for hospitalized patients with moderate to severe COVID-19 pneumonia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::892a056b9452b5dbb04ff12471c83cc9
https://doi.org/10.21055/preprints-3111821
https://doi.org/10.21055/preprints-3111821
Autor:
Andrey Ivashchenko, Andrey Svistunov, Tatiana Khorobryh, Vladimir Loginov, Ruben Karapetian, Natalia Mishchenko, Stanislav Poyarkov, Maxim Volgin, Elena Yakubova, Michael Topr, Oleg Pyankov, Anastasia Magerramova, Alexey Tomilov, Alexandre Ivashchenko
The efficacy of Aprotinin as prophylactic treatment of Covid-19 was studied in the hamster model of SARS-CoV-2 and in the health care personnel working with Covid-19 patients in hospital. High efficacy of Aprotinin in pre- and post-exposure prophylax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee0c07d5698ec5a1d5e14553861b8f9
https://doi.org/10.21055/preprints-3111813
https://doi.org/10.21055/preprints-3111813